China drug regulator calling on international pharmaceutical companies to bring “urgently-needed” new drugs to China

On 8 August 2018, in an unprecedented regulatory action, the China National Drug Administration (CNDA) called on international pharmaceutical companies to bring 48 new drugs to China. These new drugs are viewed to be urgently needed in China and have already been approved and marketed in the U.S., EU, and Japan for rare diseases or other life-threatening diseases and conditions.

Click here to read the full article.


Download PDF Share Back To Listing
Loading data